SHPG : Summary for Shire plc - American Depositary - Yahoo Finance

U.S. Markets close in 5 hrs 25 mins

Shire plc (SHPG)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
167.39-2.83 (-1.66%)
As of 10:35AM EST. Market open.
People also watch
JAZZALXNBMRNMNKICPT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close170.22
Open169.52
Bid167.52 x 100
Ask167.64 x 100
Day's Range167.25 - 169.55
52 Week Range161.55 - 209.22
Volume317,095
Avg. Volume1,342,025
Market Cap51.44B
Beta1.59
PE Ratio (TTM)255.95
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield0.80 (0.47%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • MarketWatch4 days ago

    FTSE 100 continues record run, rising for 14th day in a row

    U.K. stocks gained for a 14th straight day on Friday, extending their record winning run as a soft pound helped spur investors to buy into British multinationals.

  • Benzinga5 days ago

    KemPharm CEO On Recent Results, Catalysts And Prospects: 'ADHD Is By Far The Larger Market Opportunity'

    On Monday, KemPharm Inc (NASDAQ: KMPH ) reported encouraging results from its exploratory Phase 1 study assessing the pharmacokinetics, safety and intranasal abuse potential of KP511 Active Pharmaceutical ...

  • American City Business Journals5 days ago

    Lawsuit accuses Shire of monopolizing market for ADHD drug

    A new class action lawsuit accuses Shire plc’s U.S. subsidiary in Lexington of monopolizing the market for its ADHD drug Intuniv by conspiring with Actavis to delay the commercial release of a cheaper generic version. New Jersey-based Actavis (NYSE:ACT) won FDA approval to launch a cheaper, generic version of Intuniv in October 2012. Shire was effectively paying Actavis “tens of millions of dollars” to maintain a monopoly, the suit claimed.